Compare PBHC & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PBHC | LENZ |
|---|---|---|
| Founded | 1859 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.9M | 106.8M |
| IPO Year | 2014 | 2021 |
| Metric | PBHC | LENZ |
|---|---|---|
| Price | $16.96 | $4.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $14.83 |
| AVG Volume (30 Days) | 2.5K | ★ 1.2M |
| Earning Date | 11-02-2026 | 10-28-2026 |
| Dividend Yield | ★ 2.40% | N/A |
| EPS Growth | ★ 46.25 | N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | N/A | ★ $19,088,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $125.50 |
| P/E Ratio | $35.53 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.06 | $2.80 |
| 52 Week High | $18.30 | $32.13 |
| Indicator | PBHC | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 52.01 | 59.75 |
| Support Level | $16.71 | $3.60 |
| Resistance Level | $17.05 | $6.11 |
| Average True Range (ATR) | 0.17 | 0.39 |
| MACD | -0.01 | 0.14 |
| Stochastic Oscillator | 60.76 | 84.71 |
Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.